Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
Add more filters

Publication year range
1.
Am J Primatol ; 83(5): e23247, 2021 05.
Article in English | MEDLINE | ID: mdl-33660885

ABSTRACT

Captive breeding is vital for primate conservation, with modern zoos serving a crucial role in breeding populations of threatened species and educating the general public. However, captive populations can experience welfare issues that may also undermine their reproductive success. To enhance the wellbeing of endangered zoo primates, we conducted a study to assess the effects of a new scent enrichment program on captive red-ruffed lemurs (Varecia rubra), black howler monkeys (Alouatta caraya), siamangs (Symphalangus syndactylus), lar gibbons (Hylobates lar) and orangutans (Pongo pygmaeus pygmaeus). We combined behavioral observations and fecal endocrinology analyses to evaluate the effects of a series of essential oils (benzoin, lavender, lemongrass) on five captive troops (N = 19) housed at Dudley Zoo & Castle and Twycross Zoo (UK). We recorded observations of natural species-specific and abnormal stress-related behaviors for 480 h using instantaneous scan sampling. We collected 189 fecal samples and measured the fecal cortisol concentrations using radioimmunoassay. We found a significant effect of the scent enrichment on behaviors, with red-ruffed lemurs and black howler monkeys reducing their social interactions, as well as red-ruffed lemurs and lar gibbons decreasing their stress-related behaviors after they were exposed to the series of essential oils. We also found that red-ruffed lemurs displayed a significant increase in fecal glucocorticoids following exposure to essential oils. Our contradictory findings suggest that the effects of this series of essential oils may change depending on the species-specific social lives and olfactory repertoires of primates. In conclusion, we cannot recommend using these essential oils widely with zoo primates without additional evaluation.


Subject(s)
Lemuridae , Odorants , Animals , Animals, Zoo , Primates , Smell
2.
Malar J ; 16(1): 150, 2017 04 17.
Article in English | MEDLINE | ID: mdl-28415996

ABSTRACT

BACKGROUND: The I164L mutation on the dhfr gene confers high level resistance to sulfadoxine-pyrimethamine (SP) but it is rare in Africa except in a cluster of reports where prevalence >10% in highland areas of southwest Uganda and eastern Rwanda. The occurrence of the dhfr I164L mutation was investigated in community surveys in this area and examined the relationship to migration. METHODS: A cross-sectional prevalence survey was undertaken in among villages within the catchment areas of two health facilities in a highland site (Kabale) and a highland fringe site (Rukungiri) in 2007. Sociodemographic details, including recent migration, were collected for each person included in the study. A total of 206 Plasmodium falciparum positive subjects were detected by rapid diagnostic test; 203 in Rukungiri and 3 in Kabale. Bloodspot samples were taken and were screened for dhfr I164L. RESULTS: Sequence analysis confirmed the presence of the I164L mutations in twelve P. falciparum positive samples giving an estimated prevalence of 8.6% in Rukungiri. Of the three parasite positive samples in Kabale, none had I164L mutations. Among the twelve I164L positives three were male, ages ranged from 5 to 90 years of age. None of those with the I164L mutation had travelled in the 8 weeks prior to the survey, although three were from households from which at least one household member had travelled during that period. Haplotypes were determined in non-mixed infections and showed the dhfr I164L mutation occurs in both as a N51I + S108N + I164L haplotype (n = 2) and N51I + C59R + S108N + I164L haplotype (n = 5). Genotyping of flanking microsatellite markers showed that the I164L occurred independently on the triple mutant (N51I, C59R + S108N) and double mutant (N51I + S108N) background. CONCLUSIONS: There is sustained local transmission of parasites with the dhfr I164L mutation in Rukungiri and no evidence to indicate its occurrence is associated with recent travel to highly resistant neighbouring areas. The emergence of a regional cluster of I164L in SW Uganda and Rwanda indicates that transmission of I164L is facilitated by strong drug pressure in low transmission areas potentially catalysed in those areas by travel and the importation of parasites from relatively higher transmission settings.


Subject(s)
Drug Resistance , Malaria, Falciparum/parasitology , Mutation, Missense , Plasmodium falciparum/enzymology , Tetrahydrofolate Dehydrogenase/genetics , Travel , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Cross-Sectional Studies , Female , Gene Frequency , Haplotypes , Humans , Infant , Infant, Newborn , Malaria, Falciparum/epidemiology , Male , Middle Aged , Plasmodium falciparum/drug effects , Plasmodium falciparum/isolation & purification , Prevalence , Selection, Genetic , Sequence Analysis, DNA , Surveys and Questionnaires , Uganda/epidemiology , Young Adult
3.
Nature ; 460(7253): 376-9, 2009 Jul 16.
Article in English | MEDLINE | ID: mdl-19606146

ABSTRACT

Oceanic sediments from long cores drilled on the Lomonosov ridge, in the central Arctic, contain ice-rafted debris (IRD) back to the middle Eocene epoch, prompting recent suggestions that ice appeared in the Arctic about 46 million years (Myr) ago. However, because IRD can be transported by icebergs (derived from land-based ice) and also by sea ice, IRD records are restricted to providing a history of general ice-rafting only. It is critical to differentiate sea ice from glacial (land-based) ice as climate feedback mechanisms vary and global impacts differ between these systems: sea ice directly affects ocean-atmosphere exchanges, whereas land-based ice affects sea level and consequently ocean acidity. An earlier report assumed that sea ice was prevalent in the middle Eocene Arctic on the basis of IRD, and although somewhat preliminary supportive evidence exists, these data are neither comprehensive nor quantified. Here we show the presence of middle Eocene Arctic sea ice from an extraordinary abundance of a group of sea-ice-dependent fossil diatoms (Synedropsis spp.). Analysis of quartz grain textural characteristics further supports sea ice as the dominant transporter of IRD at this time. Together with new information on cosmopolitan diatoms and existing IRD records, our data strongly suggest a two-phase establishment of sea ice: initial episodic formation in marginal shelf areas approximately 47.5 Myr ago, followed approximately 0.5 Myr later by the onset of seasonally paced sea-ice formation in offshore areas of the central Arctic. Our data establish a 2-Myr record of sea ice, documenting the transition from a warm, ice-free environment to one dominated by winter sea ice at the start of the middle Eocene climatic cooling phase.


Subject(s)
Cold Climate , Diatoms/isolation & purification , Ice Cover/chemistry , Ice Cover/microbiology , Arctic Regions , Diatoms/chemistry , Diatoms/ultrastructure , Fossils , Geologic Sediments/microbiology , History, Ancient , Hydrogen-Ion Concentration , Microscopy, Electron, Scanning , Oceans and Seas , Principal Component Analysis , Salinity , Seawater/chemistry , Silicon Dioxide/analysis
4.
Emerg Infect Dis ; 20(8): 1280-6, 2014 Aug.
Article in English | MEDLINE | ID: mdl-25061906

ABSTRACT

Super-resistant Plasmodium falciparum threatens the effectiveness of sulfadoxine-pyrimethamine in intermittent preventive treatment for malaria during pregnancy. It is characterized by the A581G Pfdhps mutation on a background of the double-mutant Pfdhps and the triple-mutant Pfdhfr. Using samples collected during 2004-2008, we investigated the evolutionary origin of the A581G mutation by characterizing microsatellite diversity flanking Pfdhps triple-mutant (437G+540E+581G) alleles from 3 locations in eastern Africa and comparing it with double-mutant (437G+540E) alleles from the same area. In Ethiopia, both alleles derived from 1 lineage that was distinct from those in Uganda and Tanzania. Uganda and Tanzania triple mutants derived from the previously characterized southeastern Africa double-mutant lineage. The A581G mutation has occurred multiple times on local Pfdhps double-mutant backgrounds; however, a novel microsatellite allele incorporated into the Tanzania lineage since 2004 illustrates the local expansion of emergent triple-mutant lineages.


Subject(s)
Drug Resistance , Folic Acid Antagonists/pharmacology , Malaria, Falciparum/epidemiology , Malaria, Falciparum/parasitology , Plasmodium falciparum/drug effects , Adolescent , Alleles , Child , Child, Preschool , Dihydropteroate Synthase/genetics , Drug Resistance/genetics , Ethiopia/epidemiology , Gene Frequency , Haplotypes , Humans , Infant , Microsatellite Repeats , Mutation , Plasmodium falciparum/genetics , Tanzania/epidemiology , Tetrahydrofolate Dehydrogenase/genetics , Uganda/epidemiology , Young Adult
5.
Malar J ; 13: 392, 2014 Oct 02.
Article in English | MEDLINE | ID: mdl-25277367

ABSTRACT

BACKGROUND: Even though Plasmodium vivax has the widest worldwide distribution of the human malaria species and imposes a serious impact on global public health, the investigation of genetic diversity in this species has been limited in comparison to Plasmodium falciparum. Markers of genetic diversity are vital to the evaluation of drug and vaccine efficacy, tracking of P. vivax outbreaks, and assessing geographical differentiation between parasite populations. METHODS: The genetic diversity of eight P. vivax populations (n=543) was investigated by using two microsatellites (MS), m1501 and m3502, chosen because of their seven and eight base-pair (bp) repeat lengths, respectively. These were compared with published data of the same loci from six other P. vivax populations. RESULTS: In total, 1,440 P. vivax samples from 14 countries on three continents were compared. There was highest heterozygosity within Asian populations, where expected heterozygosity (He) was 0.92-0.98, and alleles with a high repeat number were more common. Pairwise FST revealed significant differentiation between most P. vivax populations, with the highest divergence found between Asian and South American populations, yet the majority of the diversity (~89%) was found to exist within rather than between populations. CONCLUSIONS: The MS markers used were informative in both global and local P. vivax population comparisons and their seven and eight bp repeat length facilitated population comparison using data from independent studies. A complex spatial pattern of MS polymorphisms among global P. vivax populations was observed which has potential utility in future epidemiological studies of the P. vivax parasite.


Subject(s)
Malaria, Vivax/parasitology , Microsatellite Repeats , Plasmodium vivax/genetics , Asia , Genetic Variation , Humans , South America , Sudan
6.
J Infect Dis ; 207(5): 848-59, 2013 Mar 01.
Article in English | MEDLINE | ID: mdl-23225897

ABSTRACT

BACKGROUND: Intermittent preventive treatment in infants (IPTi) is the administration of sulfadoxine-pyrimethamine (SP) at 2, 3, and 9 months of age to prevent malaria. We investigated the influence of IPTi on drug resistance. METHODS: Twenty-four areas were randomly assigned to receive or not receive IPTi. Blood collected during representative household surveys at baseline and 15 and 27 months after implementation was tested for SP and resistance markers. RESULTS: The frequency of SP in blood was similar in the IPTi and comparison areas at baseline and at 15 months. dhfr and dhps mutations were also similar at baseline and then increased similarly in both arms after 15 months of SP-IPTi. First-line treatment was switched from SP to artemether-lumefantrine before the final survey, when SP positivity fell among infants in comparison areas but increased in IPTi areas. This was accompanied by an increase in dhfr but not dhps mutations in IPTi areas (P = .004 and P = .18, respectively). CONCLUSIONS: IPTi did not increase drug pressure or the selection on dhfr and dhps mutants, when SP was the first-line malaria treatment. Introduction of artemether-lumefantrine was followed by an increase in dhfr mutations, consistent with weak selection attributable to SP-IPTi, but not by an increase in dhps mutations, suggesting a fitness cost of this mutation.


Subject(s)
Antimalarials/administration & dosage , Drug Administration Schedule , Drug Resistance , Malaria/prevention & control , Malaria/parasitology , Plasmodium/drug effects , Pyrimethamine/administration & dosage , Sulfadoxine/administration & dosage , Antimalarials/blood , Antimalarials/pharmacology , Drug Combinations , Female , Humans , Infant , Male , Mutation , Peptide Synthases/genetics , Pyrimethamine/blood , Pyrimethamine/pharmacology , Selection, Genetic , Sulfadoxine/blood , Sulfadoxine/pharmacology , Tanzania , Tetrahydrofolate Dehydrogenase/genetics
7.
Am Surg ; 89(6): 2928-2930, 2023 Jun.
Article in English | MEDLINE | ID: mdl-35392684

ABSTRACT

The Ottawa Ankle Rule and Canadian C-Spine Rule were created to guide the utility of radiographic studies. There are no guidelines to guide X-rays within trauma. Our objective was to evaluate which findings have the highest yield for determining fractures on skeletal x-ray. A retrospective study was performed on 5050 patients at a level one trauma center from January 2018 through October 2019. 2382 patients received X-Rays. Our analysis focused on five categories: limb deformity/obvious open fracture, abrasions, hematoma/contusion/sprain, laceration, and skin tear. Standard demographic and outcome variables were collected. While the cost burden on an overwhelmed system, time in the trauma bay prior to disposition and radiation exposure has not been fully evaluated, our evidence shows that X-Rays ordered for soft tissue defects are less sensitive at identifying fracture (0.0-6.9% fracture detection rate, P = 0.00) than when ordered for limb deformity or obvious fracture.


Subject(s)
Contusions , Fractures, Bone , Humans , X-Rays , Trauma Centers , Retrospective Studies , Canada , Fractures, Bone/diagnostic imaging
8.
Malar J ; 10: 317, 2011 Oct 26.
Article in English | MEDLINE | ID: mdl-22029848

ABSTRACT

BACKGROUND: Sulphadoxine-pyrimethamine (SP) resistance is now widespread throughout east and southern Africa and artemisinin compounds in combination with synthetic drugs (ACT) are recommended as replacement treatments by the World Health Organization (WHO). As well as high cure rates, ACT has been shown to slow the development of resistance to the partner drug in areas of low to moderate transmission. This study looked for evidence of protection of the partner drug in a high transmission African context. The evaluation was part of large combination therapy pilot implementation programme in Tanzania, the Interdisciplinary Monitoring Programme for Antimalarial Combination Therapy (IMPACT-TZ) METHODS: The growth of resistant dhfr in a parasite population where SP Monotherapy was the first-line treatment was measured for four years (2002-2006), and compared with the development of resistant dhfr in a neighbouring population where SP + artesunate (SP+AS) was used as the first-line treatment during the same interval. The effect of the differing treatment regimes on the emergence of resistance was addressed in three ways. First, by looking at the rate of increase in frequency of pre-existing mutant dhfr alleles under monotherapy and combination therapy. Second, by examining whether de-novo mutant alleles emerged under either treatment. Finally, by measuring diversity at three dhfr flanking microsatellite loci upstream of the dhfr gene. RESULTS: The reduction in SP selection pressure resulting from the adoption of ACT slowed the rate of increase in the frequency of the triple mutant resistant dhfr allele. Comparing between the two populations, the higher levels of genetic diversity in sequence flanking the dhfr triple mutant allele in the population where the ACT regimen had been used indicates the reduction in SP selection pressure arising from combination therapy. CONCLUSION: The study demonstrated that, alleles containing two mutations at the dhfr have arisen at least four times independently while those containing triple mutant dhfr arose only once, and were found carrying a single unique Asian-type flanking sequence, which apparently drives the spread of pyrimethamine resistance associated dhfr alleles in east Africa. SP+AS is not recommended for use in areas where SP cure rates are less than 80% but this study reports an observed principle of combination protection from an area where pyrimethamine resistance was already high.


Subject(s)
Antimalarials/pharmacology , Drug Resistance , Malaria, Falciparum/parasitology , Plasmodium falciparum/enzymology , Pyrimethamine/pharmacology , Selection, Genetic , Sulfadoxine/pharmacology , Tetrahydrofolate Dehydrogenase/genetics , Adult , Artemisinins/pharmacology , Artemisinins/therapeutic use , Artesunate , Child , Child, Preschool , Drug Combinations , Gene Frequency , Genotype , Humans , Malaria, Falciparum/drug therapy , Microsatellite Repeats , Mutation , Plasmodium falciparum/drug effects , Plasmodium falciparum/genetics , Pyrimethamine/therapeutic use , Sulfadoxine/therapeutic use , Tanzania
9.
Antimicrob Agents Chemother ; 54(8): 3121-5, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20498318

ABSTRACT

The therapeutic efficacy of sulfadoxine-pyrimethamine (SP) in treating uncomplicated Plasmodium falciparum malaria is unevenly distributed in Colombia. The Andes mountain range separates regions in the west where malaria is endemic from those in the east and constitutes a barrier against gene flow and the dispersal of parasite populations. The distribution of dhfr and dhps genotypes of 146 P. falciparum samples from the eastern Amazon and Orinoco basins and Northwest and Southwest Pacific regions of Colombia was consistent with the documented levels of therapeutic efficacy of SP. The diversity of four dhfr- and dhps-linked microsatellites indicated that double- and triple-mutant alleles for both resistance loci have a single origin. Likewise, multilocus association genotypes, including two unlinked microsatellite loci, suggested that genetic exchanges between the eastern Orinoco and Northwest Pacific populations has taken place across the Andes, most probably via migration of infected people.


Subject(s)
Antimalarials/pharmacology , Drug Resistance/genetics , Emigration and Immigration , Malaria, Falciparum/transmission , Plasmodium falciparum/drug effects , Pyrimethamine/pharmacology , Sulfadoxine/pharmacology , Alleles , Animals , Antimalarials/therapeutic use , Colombia/epidemiology , Dihydropteroate Synthase/genetics , Drug Combinations , Gene Frequency , Genotype , Humans , Malaria, Falciparum/drug therapy , Malaria, Falciparum/epidemiology , Malaria, Falciparum/parasitology , Microsatellite Repeats , Molecular Sequence Data , Parasitic Sensitivity Tests , Plasmodium falciparum/genetics , Pyrimethamine/therapeutic use , Sequence Analysis, DNA , Sulfadoxine/therapeutic use , Tetrahydrofolate Dehydrogenase/genetics
10.
Malar J ; 9: 190, 2010 Jul 05.
Article in English | MEDLINE | ID: mdl-20602754

ABSTRACT

BACKGROUND: It is argued that, the efficacy of anti-malarials could be prolonged through policy-mediated reductions in drug pressure, but gathering evidence of the relationship between policy, treatment practice, drug pressure and the evolution of resistance in the field is challenging. Mathematical models indicate that drug coverage is the primary determinant of drug pressure and the driving force behind the evolution of drug resistance. These models show that where the basis of resistance is multigenic, the effects of selection can be moderated by high recombination rates, which disrupt the associations between co-selected resistance genes. METHODS: To test these predictions, dhfr and dhps frequency changes were measured during 2000-2001 while SP was the second-line treatment and contrasted these with changes during 2001-2002 when SP was used for first-line therapy. Annual cross sectional community surveys carried out before, during and after the policy switch in 2001 were used to collect samples. Genetic analysis of SP resistance genes was carried out on 4,950 Plasmodium falciparum infections and the selection pressure under the two policies compared. RESULTS: The influence of policy on the parasite reservoir was profound. The frequency of dhfr and dhps resistance alleles did not change significantly while SP was the recommended second-line treatment, but highly significant changes occurred during the subsequent year after the switch to first line SP. The frequency of the triple mutant dhfr (N51I,C59R,S108N) allele (conferring pyrimethamine resistance) increased by 37% - 63% and the frequency of the double A437G, K540E mutant dhps allele (conferring sulphadoxine resistance) increased 200%-300%. A strong association between these unlinked alleles also emerged, confirming that they are co-selected by SP. CONCLUSION: The national policy change brought about a shift in treatment practice and the resulting increase in coverage had a substantial impact on drug pressure. The selection applied by first-line use is strong enough to overcome recombination pressure and create significant linkage disequilibrium between the unlinked genetic determinants of pyrimethamine and sulphadoxine resistance, showing that recombination is no barrier to the emergence of resistance to combination treatments when they are used as the first-line malaria therapy.


Subject(s)
Antimalarials/therapeutic use , Drug Resistance/genetics , Malaria, Falciparum/drug therapy , Plasmodium falciparum/drug effects , Point Mutation/genetics , Pyrimethamine/therapeutic use , Sulfadoxine/therapeutic use , Alleles , Cross-Sectional Studies , Drug Combinations , Haplotypes , Humans , Membrane Transport Proteins/genetics , Plasmodium falciparum/genetics , Plasmodium falciparum/isolation & purification , Polymerase Chain Reaction/methods , Polymorphism, Single Nucleotide , Protozoan Proteins/genetics , Pyrimethamine/pharmacology , Sequence Analysis, DNA , Sulfadoxine/pharmacology , Tanzania , Tetrahydrofolate Dehydrogenase/genetics
11.
Sci Total Environ ; 722: 137745, 2020 Jun 20.
Article in English | MEDLINE | ID: mdl-32199357

ABSTRACT

Many lakes undergo anthropogenically driven eutrophication and pollution leading to decreased water and sediment quality. These effects can enhance seasonally changing lake redox conditions that may concentrate potentially toxic elements. Here we report the results of a multi-method geochemical and sediment microfabric analysis applied to reconstruct the history of cultural eutrophication and pollution of the North and South Basins of Windermere, UK. Eutrophication developed from the mid-19th to the earliest 20th centuries. Enhanced lake productivity is indicated by increased sedimentary δ13C, and increased pollution by a higher concentration of metals (Pb, Hg, and As) in the sediment, likely enhanced by incorporation and adsorption to settling diatom aggregates, preserved as sedimentary laminae. In the South Basin, increasing sediment δ15N values occur in step with Zn, Hg, and Cu, linking metal enrichment to isotopically heavy nitrate (N) from anthropogenic sources. From around 1930, decreases in Mn and Fe-rich laminae indicate reduced deep-water ventilation, whereas periods of sediment anoxia increased, being most severe in the deeper North Basin. Strongly reducing sediment conditions promoted Fe and Mn reduction and Pb-bearing barite formation, hitherto only described from toxic mine wastes and contaminated soils. From 1980 there was an increase in indicators of bottom water oxygenation, although not to before 1930. But in the South Basin, the continued impacts of sewage are indicated by elevated sediment δ15N. Imaging and X-ray microanalysis using scanning electron microscopy has shown seasonal-scale redox mineralisation of Mn, Fe, and Ba related to intermittent sediment anoxia. Elevated concentrations of these metals and As also occur in the surficial sediment and provide evidence for dynamic redox mobilisation of potentially toxic elements to the lake water. Concentrations of As (up to 80 ppm), exceed international Sediment Quality Standards. This process may become more prevalent in the future with climate change driving lengthened summer stratification.

12.
PLoS Med ; 6(4): e1000055, 2009 Apr 14.
Article in English | MEDLINE | ID: mdl-19365539

ABSTRACT

BACKGROUND: Although the molecular basis of resistance to a number of common antimalarial drugs is well known, a geographic description of the emergence and dispersal of resistance mutations across Africa has not been attempted. To that end we have characterised the evolutionary origins of antifolate resistance mutations in the dihydropteroate synthase (dhps) gene and mapped their contemporary distribution. METHODS AND FINDINGS: We used microsatellite polymorphism flanking the dhps gene to determine which resistance alleles shared common ancestry and found five major lineages each of which had a unique geographical distribution. The extent to which allelic lineages were shared among 20 African Plasmodium falciparum populations revealed five major geographical groupings. Resistance lineages were common to all sites within these regions. The most marked differentiation was between east and west African P. falciparum, in which resistance alleles were not only of different ancestry but also carried different resistance mutations. CONCLUSIONS: Resistant dhps has emerged independently in multiple sites in Africa during the past 10-20 years. Our data show the molecular basis of resistance differs between east and west Africa, which is likely to translate into differing antifolate sensitivity. We have also demonstrated that the dispersal patterns of resistance lineages give unique insights into recent parasite migration patterns.


Subject(s)
Antimalarials/pharmacology , Dihydropteroate Synthase/genetics , Drug Resistance/genetics , Malaria, Falciparum/drug therapy , Membrane Transport Proteins/genetics , Plasmodium falciparum/drug effects , Protozoan Proteins/genetics , Africa/epidemiology , Alleles , Animals , Antimalarials/therapeutic use , Chloroquine/pharmacology , Chloroquine/therapeutic use , DNA, Protozoan/genetics , Drug Combinations , Humans , Malaria, Falciparum/epidemiology , Malaria, Falciparum/parasitology , Malaria, Falciparum/prevention & control , Microsatellite Repeats , Phylogeny , Plasmodium falciparum/enzymology , Plasmodium falciparum/genetics , Plasmodium falciparum/isolation & purification , Polymorphism, Single Nucleotide , Population Surveillance , Pyrimethamine/pharmacology , Pyrimethamine/therapeutic use , Selection, Genetic , Sulfadoxine/pharmacology , Sulfadoxine/therapeutic use
13.
Antimicrob Agents Chemother ; 53(8): 3405-10, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19433569

ABSTRACT

Treatment of acute malaria caused by Plasmodium falciparum may include long-half-life drugs, such as the antifolate combination sulfadoxine-pyrimethamine (SP), to provide posttreatment chemoprophylaxis against parasite recrudescence or delayed emergence from the liver. An unusual case of P. falciparum recrudescence in a returned British traveler who received such a regimen, as well as a series of 44 parasite isolates from the same hospital, was analyzed by PCR and direct DNA sequencing for the presence of markers of parasite resistance to chloroquine and antifolates. The index patient harbored a mixture of wild-type and resistant pfdhfr and pfdhps alleles upon initial presentation. During his second malaria episode, he harbored only resistant parasites, with the haplotypes IRNI (codons 51, 59, 108, and 164) and SGEAA (codons 436, 437, 540, 581, and 613) at these two loci, respectively. Analysis of isolates from 44 other patients showed that the pfdhfr haplotype IRNI was common (found in 81% of cases). The SGEAA haplotype of pfdhps was uncommon (found only in eight cases of East African origin [17%]). A previously undescribed mutation, I431V, was observed for seven cases of Nigerian origin, occurring as one of two haplotypes, VAGKGS or VAGKAA. The presence of this mutation was also confirmed in isolates of Nigerian origin from the United Kingdom Malaria Reference Laboratory. The presence of the pfdhps haplotype SGEAA in P. falciparum parasites of East African origin appears to compromise the efficacy of treatment regimens that include SP as a means to prevent recrudescence. Parasites with novel pfdhps haplotypes are circulating in West Africa. The response of these parasites to chemotherapy needs to be evaluated.


Subject(s)
Dihydropteroate Synthase/genetics , Malaria, Falciparum/parasitology , Plasmodium falciparum/enzymology , Plasmodium falciparum/genetics , Adult , Alleles , Amino Acid Sequence , Animals , Antimalarials/therapeutic use , Atovaquone/therapeutic use , Chloroquine/pharmacology , Chloroquine/therapeutic use , Drug Combinations , Drug Resistance/genetics , Folic Acid Antagonists/therapeutic use , Haplotypes/genetics , Humans , Malaria, Falciparum/drug therapy , Male , Plasmodium falciparum/drug effects , Polymerase Chain Reaction , Proguanil/therapeutic use , Pyrimethamine/therapeutic use , Sequence Analysis, DNA , Sulfadoxine/therapeutic use , Tetrahydrofolate Dehydrogenase/genetics , United Kingdom
14.
Am J Med Genet A ; 149A(6): 1290-2, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19449423

ABSTRACT

Odontoid hypoplasia is a developmental abnormality, which is often asymptomatic. However significant sequelae can occur in some individuals, particularly after head or neck trauma. This anomaly is not generally known to be familial. We report on four affected individuals in the same family with odontoid hypoplasia, suggesting autosomal dominant inheritance. This is an important observation in that evaluation of family members is warranted in order to identify those at risk of neurologic compromise.


Subject(s)
Nuclear Family , Odontoid Process/pathology , Atlanto-Axial Joint/physiopathology , Cervical Vertebrae/diagnostic imaging , Cervical Vertebrae/pathology , Cervical Vertebrae/surgery , Female , Humans , Joint Instability/physiopathology , Laminectomy , Odontoid Process/diagnostic imaging , Radiography
15.
Trop Med Int Health ; 14(10): 1251-7, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19708897

ABSTRACT

OBJECTIVES: To assess the extent of drug resistance in Uige through molecular genetic analysis and to test whether the dhfr triple mutant alleles present in Angola are of southeast Asian origin. METHODS: Seventy-one samples of blood from children admitted to the Pediatric Emergency Unit of Uige Provincial Hospital in 2004 were screened for resistance mutations at pfcrt, pfmdr1, pfdhfr, pfdhps and pfATPase6. RESULTS: Mutations in pfcrt (codon76), pfmdr1 (codon86), pfdhfr (codons 51, 59, 108) and pfdhps (codons 436, 437) were common. Among the 66 isolates for which we were able to determine complete genetic information 13.7% carried all seven of these mutations. Flanking microsatellite analysis revealed the triple mutant pfdhfr was derived from the southeast Asian lineage, while the N51I+S108N double mutant pfdhfr alleles are a local origin. pfATPase6 mutations were rare and S769N was not found. CONCLUSION: The parasite population of Uige Angola has high frequency mutations in pfcrt, dhfr and dhps associated with resistance to chloroquine and sulphadoxine pyrimethamine, reflecting past reliance on these two drugs which were the mainstay of treatment until recently. Our findings show that drug resistance in Uige has occurred through a combination of local drug pressure and the regional and international dispersal of resistance mutant alleles.


Subject(s)
Antimalarials/therapeutic use , Drug Resistance, Multiple/genetics , Malaria, Falciparum/drug therapy , Membrane Transport Proteins/genetics , Multidrug Resistance-Associated Proteins/genetics , Protozoan Proteins/genetics , Pyrimethamine/therapeutic use , Angola , Child , Genotype , Humans , Malaria, Falciparum/genetics , Microsatellite Repeats/genetics , Mutation/genetics
16.
Mol Cancer Ther ; 18(4): 801-811, 2019 04.
Article in English | MEDLINE | ID: mdl-30787175

ABSTRACT

ß-Arrestins are classic attenuators of G-protein-coupled receptor signaling. However, they have multiple roles in cellular physiology, including carcinogenesis. This work shows for the first time that ß-arrestins have prognostic significance for predicting metastasis and response to chemotherapy in bladder cancer. ß-Arrestin-1 (ARRB1) and ß-arrestin-2 (ARRB2) mRNA levels were measured by quantitative RT-PCR in two clinical specimen cohorts (n = 63 and 43). The role of ARRBs in regulating a stem cell-like phenotype and response to chemotherapy treatments was investigated. The consequence of forced expression of ARRBs on tumor growth and response to Gemcitabine in vivo were investigated using bladder tumor xenografts in nude mice. ARRB1 levels were significantly elevated and ARRB2 levels downregulated in cancer tissues compared with normal tissues. In multivariate analysis only ARRB2 was an independent predictor of metastasis, disease-specific-mortality, and failure to Gemcitabine + Cisplatin (G+C) chemotherapy; ∼80% sensitivity and specificity to predict clinical outcome. ARRBs were found to regulate stem cell characteristics in bladder cancer cells. Depletion of ARRB2 resulted in increased cancer stem cell markers but ARRB2 overexpression reduced expression of stem cell markers (CD44, ALDH2, and BMI-1), and increased sensitivity toward Gemcitabine. Overexpression of ARRB2 resulted in reduced tumor growth and increased response to Gemcitabine in tumor xenografts. CRISPR-Cas9-mediated gene-knockout of ARRB1 resulted in the reversal of this aggressive phenotype. ARRBs regulate cancer stem cell-like properties in bladder cancer and are potential prognostic indicators for tumor progression and chemotherapy response.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Phenotype , Stem Cells/drug effects , Stem Cells/metabolism , Urinary Bladder Neoplasms/drug therapy , beta-Arrestin 1/genetics , beta-Arrestin 2/genetics , Animals , Antimetabolites, Antineoplastic/administration & dosage , Antimetabolites, Antineoplastic/pharmacology , Antimetabolites, Antineoplastic/therapeutic use , Cell Line, Tumor , Cisplatin/administration & dosage , Cisplatin/pharmacology , Cisplatin/therapeutic use , Cohort Studies , Deoxycytidine/administration & dosage , Deoxycytidine/analogs & derivatives , Deoxycytidine/pharmacology , Deoxycytidine/therapeutic use , Drug Resistance, Neoplasm/genetics , Female , Humans , Male , Mice , Mice, Nude , Prognosis , Transfection , Tumor Burden/drug effects , Xenograft Model Antitumor Assays , beta-Arrestin 1/metabolism , beta-Arrestin 2/metabolism , Gemcitabine
17.
Protist ; 169(6): 926-957, 2018 12.
Article in English | MEDLINE | ID: mdl-30453273

ABSTRACT

Xenophyophores are important megafaunal organisms in the abyssal Clarion-Clipperton Zone (CCZ; equatorial Pacific), a region hosting commercially significant deposits of polymetallic nodules. Previous studies assigned those with attached, fan-like tests to Psammina limbata, a species described from the central CCZ based on morphology. Here, we redescribe the holotype of P. limbata and then show that limbata-like morphotypes collected in the eastern CCZ include three genetically distinct species. Psammina aff. limbata is closest morphologically to P. limbata. The others are described as P. microgranulata sp. nov. and P. rotunda sp. nov. These fan-shaped species form a well-supported clade with P. tortilis sp. nov., a morphologically variable species exhibiting features typical of both Psammina and Semipsammina. A second clade containing Psammina sp. 3, and two species questionably assigned to Galatheammina branches at the base of this group. The genus Psammina includes another 9 described species for which there are no genetic data, leaving open the question of whether Psammina as a whole is monophyletic. Our study increases the number of xenophyophore species described from the eastern CCZ from 8 to 11, with a further 25 morphotypes currently undescribed. Many additional species of these giant foraminifera undoubtedly await discovery in abyssal settings.


Subject(s)
Foraminifera/classification , Foraminifera/isolation & purification , Seawater/microbiology , Biodiversity , Foraminifera/genetics , Foraminifera/growth & development , Pacific Ocean
18.
Sci Rep ; 7: 43872, 2017 03 07.
Article in English | MEDLINE | ID: mdl-28266572

ABSTRACT

Bumblebees secrete a substance from their tarsi wherever they land, which can be detected by conspecifics. These secretions are referred to as scent-marks, which bumblebees are able to use as social cues. Although it has been found that bumblebees can detect and associate scent-marks with rewarding or unrewarding flowers, their ability at discriminating between scent-marks from bumblebees of differing relatedness is unknown. We performed three separate experiments with bumblebees (Bombus terrestris), where they were repeatedly exposed to rewarding and unrewarding artificial flowers simultaneously. Each flower type carried scent-marks from conspecifics of differing relatedness or were unmarked. We found that bumblebees are able to distinguish between 1. Unmarked flowers and flowers that they themselves had scent-marked, 2. Flowers scent-marked by themselves and flowers scent-marked by others in their nest (nestmates), and 3. Flowers scent-marked by their nestmates and flowers scent-marked by non-nestmates. The bumblebees found it more difficult to discriminate between each of the flower types when both flower types were scent-marked. Our findings show that bumblebees have the ability to discriminate between scent-marks of conspecifics, which are potentially very similar in their chemical composition, and they can use this ability to improve their foraging success.


Subject(s)
Bees/physiology , Flowers/chemistry , Odorants , Pheromones/metabolism , Animals , Bees/metabolism , Cues , Discrimination Learning/physiology , Feeding Behavior/physiology , Reward
19.
Am J Trop Med Hyg ; 94(6): 1251-1258, 2016 06 01.
Article in English | MEDLINE | ID: mdl-27022156

ABSTRACT

Serological markers, combined with spatial analysis, offer a comparatively more sensitive means by which to measure and detect foci of malaria transmission in highland areas than traditional malariometric indicators. Plasmodium falciparum parasite prevalence, seroprevalence, and seroconversion rate to P. falciparum merozoite surface protein-119 (MSP-119) were measured in a cross-sectional survey to determine differences in transmission between altitudinal strata. Clusters of P. falciparum parasite prevalence and high antibody responses to MSP-119 were detected and compared. Results show that P. falciparum prevalence and seroprevalence generally decreased with increasing altitude. However, transmission was heterogeneous with hotspots of prevalence and/or seroprevalence detected in both highland and highland fringe altitudes, including a serological hotspot at 2,200 m. Results demonstrate that seroprevalence can be used as an additional tool to identify hotspots of malaria transmission that might be difficult to detect using traditional cross-sectional parasite surveys or through vector studies. Our study findings identify ways in which malaria prevention and control can be more effectively targeted in highland or low transmission areas via serological measures. These tools will become increasingly important for countries with an elimination agenda and/or where malaria transmission is becoming patchy and focal, but receptivity to malaria transmission remains high.


Subject(s)
Malaria/transmission , Serologic Tests/methods , Adolescent , Adult , Altitude , Animals , Child , Child, Preschool , Cross-Sectional Studies , Demography , Female , Humans , Infant , Malaria/epidemiology , Male , Middle Aged , Seroepidemiologic Studies , Socioeconomic Factors , Uganda/epidemiology , Young Adult
20.
Am J Trop Med Hyg ; 72(2): 155-62, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15741552

ABSTRACT

Single nucleotide polymorphisms (SNPs) in the Plasmodium falciparum dihydrofolate reductase (dhfr), and dihydropteroate synthetase (dhps), and chloroquine resistance transporter (Pfcrt) genes are used as molecular markers of P. falciparum resistance to sulfadoxine/pyrimethamine and chloroquine. However, to be a practical tool in the surveillance of drug resistance, simpler methods for high-throughput haplotyping are warranted. Here we describe a quick and simple technique that detects dhfr, dhps, and Pfcrt SNPs using polymerase chain reaction (PCR)- and enzyme-linked immunosorbent assay (ELISA)-based technology. Biotinylated PCR products of dhfr, dhps, or Pfcrt were captured on streptavidin-coated microtiter plates and sequence-specific oligonucleotide probes (SSOPs) were hybridized with the PCR products. A stringent washing procedure enabled detection of remaining bound SSOPs and distinguished between the SNPs of dhfr, dhps, and Pfcrt with high specificity. The SSOP-ELISA compared well with a standard PCR-restriction fragment length polymorphism procedure, and gave identical positive results in more than 90% of the P. falciparum slide-positive samples tested. The SSOP-ELISA of all dhfr, dhps, or Pfcrt SNPs on 88 samples can be performed in a single day and provides quick and reproducible results. The system can potentially be modified to detect SNPs in other genes.


Subject(s)
Dihydropteroate Synthase/genetics , Drug Resistance/genetics , Plasmodium falciparum/genetics , Tetrahydrofolate Dehydrogenase/genetics , Animals , Antimalarials , Chloroquine , DNA Primers , DNA, Protozoan/analysis , Drug Combinations , Enzyme-Linked Immunosorbent Assay , Humans , Malaria, Falciparum/drug therapy , Malaria, Falciparum/epidemiology , Malaria, Falciparum/etiology , Plasmodium falciparum/isolation & purification , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Polymorphism, Single Nucleotide , Pyrimethamine , Sulfadoxine , Tanzania/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL